METAPLASTIC BREAST CARCINOMA
Clinical trials for METAPLASTIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METAPLASTIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METAPLASTIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple-drug attack targets hard-to-treat breast cancer
Disease control Recruiting nowThis study tests a three-drug combination (alpelisib, L-NMMA, and chemotherapy) in people with a rare, aggressive type of breast cancer called metaplastic breast cancer that has spread or is locally advanced and hasn't responded to prior treatments. The goal is to see if adding t…
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC